Medicaments
September 3, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesPharmacologically active compounds Androstane carbothioates ଲ-Adrenergic 1-[1-benzimidazolyl]-N-[2-(4-hydroxy-3-methoxy-phenyl)-2-hydroxy-ethyl]- 3-amino butane and salts and hydrates thereof Pack for administering medicaments to patients Devices for administering medicaments to patients Drug-containing chlorofluorocarbon aerosol propellent formulations Micronised beclomethasone dipropionate monohydrate compositions and methods of use Novel liposome composition for sustained release of steroidal drugs in lungs Pharmaceutical compositions Patent #: 4985418 InventorAssigneeApplicationNo. 753907 filed on 09/03/1991US Classes:514/171With additional active ingredientExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/59A61K 009/14 Foreign Application Priority Data1989-09-08 GBAbstractPharmaceutical compositions comprising effective amounts of salmeterol (and/or a physiologically acceptable salt thereof) and fluticasone propionate as a combined preparation for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorders.Other References
| |
